CEL — Celadon Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual balance sheet for Celadon Pharmaceuticals, fiscal year end - December 31st, millions except per share.

	2018 August 31st	2019 August 31st	2020 August 31st	R2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:		ARS	ARS	ARS	ARS
Standards:	—	IFRS	IFRS	IFRS	IFRS
Status:	fx Preliminary	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	—	5.65	5.49	3.82	5.06
Net Total Accounts Receivable
Net Total Receivables	—	0.016	0.01	0.104	1.06
Total Inventory
Prepaid Expenses
Total Current Assets	—	5.66	5.5	4.09	6.33
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	—	—	—	3.31	6.28
Net Goodwill
Net Intangible Assets
Long Term Investments
Total Assets	—	5.66	5.5	8.76	13.3
Payable / Accrued
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	—	0.021	0.03	8.58	1.2
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	—	0.033	0.042	12.9	5.58
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	—	5.63	5.46	-4.14	7.67
Total Liabilities & Shareholders' Equity	—	5.66	5.5	8.76	13.3
Total Common Shares Outstanding